Results 131 to 140 of about 8,067 (167)
Neonatal side effects of maternal labetalol treatment in severe preeclampsia
Early Human Development, 2012 Objective: Labetalol is often used in severe preeclampsia (PE). Hypotension, bradycardia and hypoglycemia are feared neonatal side effects, but may also occur in (preterm) infants regardless of labetalol exposure.
Gerda G Zeeman, Christian V Hulzebos
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Annals of Internal Medicine, 1990
The Food and Drug Administration has received 11 reports of cases (three fatal) in the United States in which hepatocellular damage was associated with labetalol. The temporal circumstances strongly implicate labetalol; the conditions of nine patients improved after cessation of labetalol therapy, and one patient had a recurrence after therapy was ...
J A, Clark, H J, Zimmerman, L A, Tanner
openaire +2 more sources
The Food and Drug Administration has received 11 reports of cases (three fatal) in the United States in which hepatocellular damage was associated with labetalol. The temporal circumstances strongly implicate labetalol; the conditions of nine patients improved after cessation of labetalol therapy, and one patient had a recurrence after therapy was ...
J A, Clark, H J, Zimmerman, L A, Tanner
openaire +2 more sources